Department of Medicine 3 – Rheumatology and Immunology

Load-induced blood marker kinetics in patients with medial knee compartment osteoarthritis are associated with accumulated load and patient reported outcome measures (2024) Mündermann A, Nüesch C, Herger S, Liphardt AM, Chammartin F, De Pieri E, Egloff C Journal article Marker position uncertainty in joint angle analysis for normal human gait — A new error-modelling approach (2024) Scheiterer E, Heinrich S, Liphardt AM, Leyendecker S Journal article CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher? (2024) Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber Bouyer R, Schett G Journal article “The Simpler, the Better.” A Qualitative Study on Digital Health Transformation in Early Adopter Rheumatology Outpatient Clinics (2024) May S, Darkow R, Knitza J, Boy K, Schwarz J, Heinze M, Hornig J, et al. Journal article Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis (2024) Siebert S, Coates LC, Schett G, Raychaudhuri SP, Chen W, Gao S, Seridi L, et al. Journal article Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies (2024) Kadam E, Javaid M, Sen P, Saha S, Ziade N, Day J, Wincup C, et al. Journal article Comparison and Improvement of CyberGlove III calibration methods (2024) Heinrich S, Michaelis J, Reiher I, Coppers B, Lohmayer M, Fleischmann ME, Kleyer A, et al. Journal article, Original article COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. (2024) Andreoli L, Lini D, Schreiber K, Parodis I, Sen P, Ravichandran N, Day J, et al. Journal article Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. (2024) Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, et al. Journal article Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis (2024) Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau AR, Li YN, Györfi AH, et al. Journal article